Browsing Category

Top Industry News

7532 posts

AstraZeneca to Invest $50 Bn in US by 2030 
By

By
AstraZeneca has announced plans to invest $50 billion in the US by 2030.   The main investment is a new multi-billion dollar US manufacturing facility that will produce drug substances for…

Biogen to Invest $2 Bn in Mfg Expansion 
By

By
Biogen has announced plans to invest an additional $2 billion in its existing manufacturing footprint in North Carolina’s Research Triangle Park (RTP). Biogen has invested approximately $10 billion in its…

FDA Names New Head of CDER   
By

By
The US Food and Drug Administration (FDA) has announced the appointment of George Francis Tidmarsh, M.D., Ph.D., as Director of the Center for Drug Evaluation and Research (CDER).  Dr. Tidmarsh…

Sanofi Completes $9.5-Bn Acquisition of Blueprint Medicines 
By

By
Sanofi has completed its acquisition of Blueprint Medicines, a Cambridge, Massachusetts-based bio/pharmaceutical company specializing in rare diseases, in a $9.5-billion deal ($9.1 billion upfront and up to $400 million in…

Supplier News: Solvias, Sanner, Stevanato & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Solvias, Sanner, Stevanato Group, Abzena, Coriolis Pharma and Roquette.   Biologics Manufacturing * Solvias Opens Center of Excellence for Biologics & New Modalities Formulation Development/Drug…

Global Briefs: Moderna, Sarepta, Sanofi & More 
By

By
A roundup of news from Moderna, Sarepta Therapeutics, Sanofi, UK Government, GenesisM and Johnson & Johnson/Pacira Biosciences. Highlights below.   Mfg News * Moderna Nixes Plan for mRNA Mfg Plant in Japan *…

Thermo Fisher To Acquire Sterile Mfg Site from Sanofi 
By

By
Thermo Fisher Scientific has agreed to acquire Sanofi’s sterile manufacturing site in Ridgefield, New Jersey. The Ridgefield site is a sterile fill-finish and packaging facility with more than 200 employees,…

Kenvue, Former J&J Consumer Health Care Business, Announces CEO Transition 
By

By
Kenvue, the former consumer healthcare business of Johnson & Johnson, is making a CEO transition as it advances an ongoing comprehensive review of strategic alternatives. The Board has appointed Kirk…

Gene Therapy Company Sarepta Therapeutics Restructuring; Cutting One-Third of Workforce 
By

By
Sarepta Therapeutics, a Cambridge, Massachusetts-based genetics medicines company, has announced a strategic restructuring plan, which would result in eliminating approximately one-third of its workforce.   Sarepta has initiated immediate changes to…

Supplier News: Bora, PCI, Fareva & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Bora Pharmaceuticals, PCI Pharma Services, Fareva, Zhaoke, Almac, and Tobin Scientific.   Formulation Development/Drug Product Manufacturing * Bora Pharmaceuticals Adds Filling Line to Mfg…